Zhenxin Zhang
Beijing, 100730, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer's dementia.
Journal: Alzheimer's research & therapy
Published: November 12, 2020
Standardized Operational Protocol for Human Brain Banking in China.
Journal: Neuroscience bulletin
Published: July 03, 2018
An open-label extension study to evaluate the safety of ropinirole prolonged release in Chinese patients with advanced Parkinson's disease.
Journal: Current medical research and opinion
Published: January 15, 2015
Erratum to "A novel mutation in the PSEN2 gene (N141Y) associated with early-onset autosomal dominant Alzheimer's disease in a Chinese Han family" [Neurobiol. Aging 35 (2014) 2420.e1-2420.e5].
Journal: Neurobiology of aging
Published: December 01, 2014
Validation of an Alzheimer's disease assessment battery in Asian participants with mild to moderate Alzheimer's disease.
Journal: American journal of neurodegenerative disease
Published: October 24, 2014
Incidence of dementia and subtypes: A cohort study in four regions in China.
Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: July 29, 2014
Assessment of cognitive impairment in patients with Parkinson's disease: prevalence and risk factors.
Journal: Clinical interventions in aging
Published: February 20, 2014
Novel mutation in the PSEN2 gene (N141Y) associated with early-onset autosomal dominant Alzheimer's disease in a Chinese Han family.
Journal: Neurobiology of aging
Published: January 09, 2014
The efficacy and safety of ropinirole prolonged release tablets as adjunctive therapy in Chinese subjects with advanced Parkinson's disease: a multicenter, double-blind, randomized, placebo-controlled study.
Journal: Parkinsonism & related disorders
Published: April 18, 2013
Galantamine versus donepezil in Chinese patients with Alzheimer's disease: results from a randomized, double-blind study.
Journal: Neuropsychiatric disease and treatment
Published: December 13, 2012
Incidence and risk factors of cognitive impairment 3 months after first-ever stroke: a cross-sectional study of 5 geographic areas of China.
Journal: Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban
Published: March 12, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026